iRhythm Holdings (IRTC) Net Income towards Common Stockholders (2015 - 2026)
iRhythm Holdings (IRTC) posted quarterly Net Income towards Common Stockholders of -$13.9 million for Q1 2026, up 54.62% year-over-year from -$9.0 million in Q1 2025, and down 349.74% quarter-over-quarter from $5.6 million in Q4 2025.
iRhythm Holdings (IRTC) Net Income towards Common Stockholders (2015 - 2026) Analysis & Trends
iRhythm Holdings (IRTC) has reported Net Income towards Common Stockholders for 12 consecutive years, with -$13.9 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Net Income towards Common Stockholders rose 54.62% year-over-year to -$13.9 million; the TTM figure through Mar 2026 stood at -$27.8 million (up 71.74% YoY), while the FY2025 annual figure was -$44.6 million, up 60.67% from the prior year.
- Net Income towards Common Stockholders declined to -$13.9 million in Q1 2026 per IRTC's latest filing, from $5.6 million in the prior quarter.
- Across five years, Net Income towards Common Stockholders topped out at $5.6 million in Q4 2025 and bottomed at -$50.6 million in Q1 2022.
- Historically, Net Income towards Common Stockholders has averaged -$24.2 million across 5 years, with a median of -$21.5 million in 2022.
- Annual changes were most pronounced in 2023 — Net Income towards Common Stockholders sank 91.6% — and 2025, when it surged 518.53%.
- iRhythm Holdings' Net Income towards Common Stockholders stood at -$20.2 million in 2022, then tumbled by 91.6% to -$38.7 million in 2023, then jumped by 96.56% to -$1.3 million in 2024, then soared by 518.53% to $5.6 million in 2025, then tumbled by 349.74% to -$13.9 million in 2026.
- Business Quant data shows IRTC's Net Income towards Common Stockholders at -$13.9 million in Q1 2026, $5.6 million in Q4 2025, and -$5.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.07 Bn | 193.46 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 127.90 Bn | 124.43 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 118.84 Bn | 109.62 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 73.33 Bn | 72.79 Bn | 3.85 Bn | 907.00 Mn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 34.46 Bn | 32.51 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 33.91 Bn | 31.81 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 621.86 Mn |
| 9 | Steris | 23.12 Bn | 22.64 Bn | 684.20 Mn | 201.00 Mn |
| 10 | iRhythm Holdings | 4.19 Bn | 3.60 Bn | 163.21 Mn | -381,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -381,000.00 |
| Mar 31, 2026 | -13.93 Mn |
| Dec 31, 2025 | 5.58 Mn |
| Sep 30, 2025 | -5.21 Mn |
| Jun 30, 2025 | -14.22 Mn |
| Mar 31, 2025 | -30.70 Mn |
| Dec 31, 2024 | -1.33 Mn |
| Sep 30, 2024 | -46.18 Mn |
| Jun 30, 2024 | -20.11 Mn |
| Mar 31, 2024 | -45.67 Mn |
| Dec 31, 2023 | -38.70 Mn |
| Sep 30, 2023 | -27.12 Mn |
| Jun 30, 2023 | -18.48 Mn |
| Mar 31, 2023 | -39.11 Mn |
| Dec 31, 2022 | -20.20 Mn |
| Sep 30, 2022 | -21.45 Mn |
| Jun 30, 2022 | -23.90 Mn |
| Mar 31, 2022 | -50.61 Mn |
| Dec 31, 2021 | -32.49 Mn |
| Sep 30, 2021 | -23.73 Mn |